Author Question: The text discusses three new city variations. Which of the following is NOT one of these? a. new ... (Read 84 times)

dollx

  • Hero Member
  • *****
  • Posts: 558
The text discusses three new city variations. Which of the following is NOT one of these?
 
  a. new city as motivator
  b. new city as a solution to problems
  c. new city as the problem
  d. new city as mediator

Question 2

__________ are new, sprawling, middle-class, automobile-dependent centers typically located at the fringe of older urban areas, at the intersections of major highways, where little except villages or farmland existed three decades earlier.
 
  a. Edge cities
  b. Growth boundaries
  c. Gated communities
  d. Common-interest developments



kxciann

  • Sr. Member
  • ****
  • Posts: 356
Answer to Question 1

d

Answer to Question 2

a



Related Topics

Need homework help now?

Ask unlimited questions for free

Ask a Question
 

Did you know?

Pink eye is a term that refers to conjunctivitis, which is inflammation of the thin, clear membrane (conjunctiva) over the white part of the eye (sclera). It may be triggered by a virus, bacteria, or foreign body in the eye. Antibiotic eye drops alleviate bacterial conjunctivitis, and antihistamine allergy pills or eye drops help control allergic conjunctivitis symptoms.

Did you know?

Lower drug doses for elderly patients should be used first, with titrations of the dose as tolerated to prevent unwanted drug-related pharmacodynamic effects.

Did you know?

The average person is easily confused by the terms pharmaceutics and pharmacology, thinking they are one and the same. Whereas pharmaceutics is the science of preparing and dispensing drugs (otherwise known as the science of pharmacy), pharmacology is the study of medications.

Did you know?

Disorders that may affect pharmacodynamics include genetic mutations, malnutrition, thyrotoxicosis, myasthenia gravis, Parkinson's disease, and certain forms of insulin-resistant diabetes mellitus.

Did you know?

Despite claims by manufacturers, the supplement known as Ginkgo biloba was shown in a study of more than 3,000 participants to be ineffective in reducing development of dementia and Alzheimer’s disease in older people.

For a complete list of videos, visit our video library